Federal oversight of healthcare is changing, with a greater emphasis on equity and consumer rights.
In this first year of the new administration, we saw some policy shifts in the area of federal health regulation. At the same time, the COVID-19 Public Health Emergency (PHE) continued to delay some expected new programs.
For one thing, the administration introduced the idea of “health equity” into the mainstream of its regulatory programs. While asking for public comment in a number of areas, the Centers for Medicare & Medicaid Services (CMS) revised some quality measures and introduced some new pilot programs to achieve better health equity in the Medicare and Medicaid programs.
We also continued to see the coverage of telehealth being expanded from pre-pandemic levels, although it appears that some commercial plans are not following suit. The usual coding updates for CPT and ICD-10 occurred, with new codes for COVID-19 and for dealing with the social determinants of health (SDoH) to help achieve equity. There were some payments increased for institutional providers. Physician Part B payments were somewhat reduced, but with a revision to help increase payments for primary care.
Price transparency, especially under the No Surprises Act regulations, continues to be important – as indicated by the recent increase in penalties for hospitals not publishing their contracted rates as required. The No Surprises Act regulations, effective Jan. 1, 2022, eliminate out-of-network charges for emergency room visits and most in-network hospital visits for commercial health plans. The regulations also will require providers to give uninsured patients price estimates for scheduled services within a few days of scheduling them. Requirements under the Act to provide insured patients with advance estimates of their costs are expected soon; but these will not be effective on Jan. 1.
And in recent regulatory news, a new interim final rule requires health plans, health insurance issuers offering group or individual coverage, and health benefit plans offered to federal employees to submit key data to several government departments, which will work through the U.S. Department of Health and Human Services (HHS) Assistant Secretary for Planning and Evaluation (ASPE) to publish a report on prescription drug pricing trends and rebates, as well as their impact on premiums and consumers’ out-of-pocket costs. Plans and issuers must now provide an annual overview of their top 50 drugs across key areas of concern, including the following:
The new data submission requirements will apply starting with data from the 2020 calendar year. However, the Departments are deferring enforcement of the new requirements until Dec. 27, 2022, to give regulated entities time to come into compliance. This means the required information for 2020 and 2021 is due by then, although it may be submitted sooner.
The lifting of regulatory limits on artificial intelligence (AI) in healthcare has the potential to revolutionize the industry, enabling faster diagnoses, more personalized treatments, and
The distinction between laws and regulations is a fundamental aspect of governance in the United States, particularly in highly regulated sectors such as healthcare. With
Please log in to your account to comment on this article.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
Sepsis remains one of the most frequently denied and contested diagnoses, creating costly revenue loss and compliance risks. In this webcast, Angela Comfort, DBA, MBA, RHIA, CDIP, CCS, CCS-P, provides practical, real-world strategies to align documentation with coding guidelines, reconcile Sepsis-2 and Sepsis-3 definitions, and apply compliant queries. You’ll learn how to identify and address documentation gaps, strengthen provider engagement, and defend diagnoses against payer scrutiny—equipping you to protect reimbursement, improve SOI/ROM capture, and reduce audit vulnerability in this high-risk area.
Only ICD10monitor delivers what you need: updates on must-know changes associated with the FY26 IPPS, including new ICD-10-CM/PCS codes, CCs/MCCs, and MS-DRGs, plus insights, analysis and answers to your questions from two of the country’s most respected subject matter experts.
This third session in our 2026 IPPS Masterclass will feature a review of FY26 changes to the MS-DRG methodology and new technology add-on payments (NTAPs), presented by nationally recognized ICD-10 coding expert Christine Geiger, MA, RHIA, CCS, CRC, with bonus insights and analysis from Dr. James Kennedy.
Federal auditors are zeroing in on Inpatient Rehabilitation Facility (IRF) and hospital rehab unit services, with OIG and CERT audits leading to millions in penalties—often due to documentation and administrative errors, not quality of care. Join compliance expert Michael Calahan, PA, MBA, to learn the five clinical “pillars” of IRF-PPS admissions, key documentation requirements, and real-life case lessons to help protect your revenue.
During this essential RACmonitor webcast Michael Calahan, PA, MBA Certified Compliance Officer, will clarify the rules, dispel common misconceptions, and equip you with practical strategies to code, document, and bill high-risk split/shared, incident-to & critical care E/M services with confidence. Don’t let audit risks or revenue losses catch your organization off guard — learn exactly what federal auditors are looking for and how to ensure your documentation and reporting stand up to scrutiny.
Learn how to navigate the proposed elimination of the Inpatient-Only list. Gain strategies to assess admission status, avoid denials, protect compliance, and address impacts across Medicare and non-Medicare payors. Essential insights for hospitals.
RACmonitor is proud to welcome back Dr. Ronald Hirsch, one of his most requested webcasts. In this highly anticipated session, Dr. Hirsch will break down the complex Two Midnight Rule Medicare regulations, translating them into clear, actionable guidance. He’ll walk you through the basics of the rule, offer expert interpretation, and apply the rule to real-world clinical scenarios—so you leave with greater clarity, confidence, and the tools to ensure compliance.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
